Ligand validation:8S38

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 8S38 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8S38_NAD_C_1407	80%	57%	0.096	0.945	0.75	0.89	1	3	0	0	100%	0.88
8S38_NAD_A_501	38%	55%	0.149	0.848	0.71	1.01	1	4	2	0	100%	0.74
8S3D_NAD_E_501	100%	62%	0.038	0.988	0.58	0.88	-	2	0	0	100%	1
8S3A_NAD_E_1108	99%	58%	0.045	0.981	0.64	0.96	-	3	0	0	100%	1
8S39_NAD_C_1205	96%	51%	0.065	0.974	0.88	1.02	2	2	0	0	100%	1
8S3B_NAD_B_508	94%	59%	0.065	0.963	0.71	0.87	1	2	0	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.